Navigating Complex Venous Pathology: Clinical Cases and Endovascular Solutions
2025-11-26 20:00 - 22:00 (America/Toronto) | Online
***Session en anglais seulement***

GUEST SPEAKER: Dr. Kathleen J. Ozsvath, Vascular Surgeon, St. Peter’s Medical Associates- Albany NY Chief of Surgery, Samaritan Hospital – St. Peter’s Health Partners- Troy NY Professor of Surgery, Albany Medical Center NY
This session will provide:

Explain Venous Disease Pathophysiology and Clinical Manifestations
Identify the Optimal Candidates – based on clinical presentation & diagnostic imaging
Review Current Treatment Options – including endovascular techniques & device selection
Outline Best Practices for Post Procedure Management
Summarize Recent Clinical Research

Registration
CAIR MEMBERS:

Event: FREE
Access to Recording: $10.00 +tax

This event is offered at NO COST for CAIR members. Please note that you need to log into your account first and select « Register for Events » link (left side menu) in the member dashboard to get the member rate. Additional information will follow and you will receive an email with the meeting registration details.
Access to the recording of the event can be purchased below.
CAIR NON-MEMBERS:
Event: $199.00 +tax
Access to Recording: $49.00 +tax

To register, add item to cart and then proceed to check out. Follow instructions to fill out personal and payment information. A confirmation email will be sent once the payment is processed. Additional information will follow and you will receive an email with the meeting registration details.
Access to the recording of the event can be purchased below.
NOT A MEMBER YET?
CAIR membership has many benefits, to join – apply here.

Navigating Complex Venous Pathology: Clinical Cases and Endovascular Solutions Event
$199.00Ajouter au panier

Navigating Complex Venous Pathology: Clinical Cases and Endovascular Solutions Access to Recording
$49.00Ajouter au panier

View your cart here.

Sponsor
CAIR programs are made possible through unrestricted education grants from our corporate partners and sponsors and are planned to achieve scientific integrity, objectivity, and balance.
